International Journal of Gerontology
Volume 3, Issue 4 , Pages 248-250, December 2009

Cholestasis and Acute Cholecystitis in Hyperthyroidism Treated With Methimazole

  • Wei-Che Chen

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei, Taiwan
    • Corresponding Author InformationCorrespondence to: Dr Wei-Che Chen, Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan
  • ,
  • Zheng-Xin Zhu

      Affiliations

    • Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan
  • ,
  • Chao-Hung Wang

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei, Taiwan
  • ,
  • Ming-Nan Chien

      Affiliations

    • Division of Endocrinology and Metabolism, Department of Internal Medicine, Taipei, Taiwan
    • Mackay Medicine, Nursing and Management College, Taipei, Taiwan

Accepted 11 March 2009.

Article Outline

Summary 

Hepatic dysfunction and jaundice are usually present in patients with hyperthyroidism. It may be the clinical manifestation of the disease or the adverse effect of antithyroid therapy. We report a 69-year-old male with hyperthyroidism who developed cholestasis and acute cholecystitis after a 4-day course of methimazole. After withdrawal of methimazole, his cholestasis subsided.

Key Words:  acute cholecystitis , cholestasis , hyperthyroidism , methimazole

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Davies TF , Larsen PR . Thyrotoxicosis . In:  Kronenberg HM ,  Melmed S ,  Polonsky KS , et al. editor. Williams Textbook of Endocrinology . 11th edition. Philadelphia: Saunders Elsevier; 2008;p. 336
  2. Arab DM , Malatjalian DA , Rittmaster RS . Severe cholestatic jaundice in uncomplicated hyperthyroidism treated with methimazole . J Clin Endocrinol Metab . 1995;80:1083–1085
  3. Habershon SO . Exophthalmic goiter, heart disease, jaundice, death . Lancet . 1874;103:510
  4. Chawla M , Bal CS . Four cases of coexistent thyrotoxicosis and jaundice: results of radioiodine treatment and a brief review . Thyroid . 2008;18:289–292
  5. Johnson PJ . The effect of endocrine disease on liver function . In:  Bircher J ,  Benhamou JP ,  McIntyre N , et al. editor. Oxford Textbook of Clinical Hepatology . Oxford: Oxford Medical Publications; 1991;p. 1195
  6. Greenspan FS . The thyroid gland . In:  Greenspan FS ,  Gardner DG editor. Basic and Clinical Endocrinology . 7th edition. New York: McGraw-Hill; 2004;p. 227–231
  7. Ohshima T , Maeda H , Takayasu T , et al.   [An autopsy case of sudden death due to hyperthyroidism] . Nihon Hoigaku Zasshi . 1990;44:365–370 [In Japanese]
  8. Owen PJD , Baghomian A , Lazarus JH , et al.   An unusual case of jaundice . BMJ . 2007;335:773–774
  9. Nobili V , Liaskos C , Luigi G , et al.   Autoimmune thyroiditis associated with autoimmune hepatitis . Thyroid . 2005;15:1193–1195
  10. Lee TM , Kuo SH , Lee YT . Reversible systolic heart failure and deep jaundice in hyperthyroidism . Am J Med Sci . 1996;312:246–248
  11. Cooper DS . Treatment of thyrotoxicosis . In:  Braverman LE ,  Utiger RD ,  Werner SC , et al. editor. The Thyroid . 7th edition. Philadelphia: Lippincott-Raven; 1996;p. 474
  12. Cooper DS . Antithyroid drugs . N Engl J Med . 2005;352:905–917

PII: S1873-9598(10)70009-0

doi:10.1016/S1873-9598(10)70009-0

International Journal of Gerontology
Volume 3, Issue 4 , Pages 248-250, December 2009